NuPathe - New Pathways in Neuroscience
Management

The NuPathe management team consists of pharmaceutical, CRO, and biotech veterans with both large and small company experience.  The NuPathe management has been responsible for the development of several successful healthcare companies and the clinical development of multiple therapeutic products currently on the market.

Jane H. Hollingsworth
Chief Executive Officer

Terri B. Sebree
President

Keith A. Goldan, CPA
Vice President and Chief Financial Officer

Suzanne M. Hanlon
VP Administration, General Counsel, Secretary

Jerry McLaughlin
VP Commercial Operations

Ezra Felker
VP Business Development

Mark W. Pierce, M.D., Ph.D.
Chief Scientific Officer

Carol O'Neill
VP Development Operations

Lynne Georgopoulos
VP Regulatory Affairs and Quality Assurance

Angel S. Angelov, M.D.
Senior Medical Director

 Home | About Us | Research and Development | Business Development | Press Room | Contact Legal Notices | Privacy Policy 
 Search  
Copyright © 2005-2008 NuPathe Inc.